Human Genome Could Be Takeover Target of Multiple Big Pharma Players - 0 views
-
Brian Plain on 17 Nov 10StockMarketFunding.com reports that Human Genome Sciences FDA Panel Recommendation for Benlysta may cause many large biotechnology players to look at HGSI as a takeover target.